Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Malignant Neoplasm
57%
Bladder Cancer
49%
Neoplasm
45%
Transitional Cell Carcinoma
39%
Androgen
34%
Epidermal Growth Factor Receptor
28%
Lung Cancer
26%
Reactive Oxygen Metabolite
26%
Inflammation
26%
Chronic Kidney Failure
24%
Androgen Receptor
23%
Non Small Cell Lung Cancer
23%
Nanoparticle
22%
Mouse
22%
Cytotoxicity
20%
Recurrent Disease
20%
Prostate Hypertrophy
20%
Quercetin
20%
Castration Resistant Prostate Cancer
20%
Cancer Growth
19%
Chemotherapy
19%
Metastasis
18%
Phosphotransferase
18%
microRNA
16%
Mitogen Activated Protein Kinase
16%
Protein P53
15%
Gelatinase A
14%
Renal Cell Carcinoma
14%
Bladder Carcinoma
14%
Prostate Specific Antigen
14%
Antioxidant
13%
Acute Myeloid Leukemia
13%
Lung Adenocarcinoma
13%
Tumor Necrosis Factor
13%
Rat Model
13%
Mouth Squamous Cell Carcinoma
13%
Caspase 3
12%
Cisplatin
12%
Therapeutic Effect
12%
Injury
12%
Cytokine
12%
Disintegrin
12%
Metalloproteinase
12%
Alginic Acid
12%
Tumor Growth
12%
Penfluridol
11%
Bicalutamide
11%
Prostaglandin E1
11%
Guava
11%
Disease
11%
Liver Cell Carcinoma
11%
Gallic Acid
11%
Western Blot
10%
Mouse Model
10%
Doxorubicin
10%
Cigarette Smoking
10%
Lipopolysaccharide
10%
Polysaccharide
10%
Cyclooxygenase 2
10%
Anti-Inflammatory Drug
9%
Caffeic Acid Phenethyl Ester
9%
Mouth Cancer
9%
Ferulic Acid
9%
Antrodia camphorata
9%
Kidney Injury
8%
Diabetes Mellitus
8%
Thrombus
8%
Adverse Event
8%
Symptom
8%
Polypyrrole
8%
Breast Cancer
8%
Cohort Study
7%
Gelatinase B
7%
Sodium Valproate
7%
Hyperthermia
7%
Apigenin
7%
Cell Viability
7%
Photothermal Therapy
7%
Sepsis
7%
Carboplatin
7%
Fibrinolytic Agent
7%
Resveratrol
7%
Carcinogenesis
7%
Tumor Suppressor Protein
7%
Gold Nanorod
7%
Uropathogenic Escherichia Coli
7%
Hydroxyapatite
7%
Repurposing
7%
Nifedipine
7%
Pummelo
7%
Leukemia
7%
Mammalian Target of Rapamycin
7%
Traumatic Brain Injury
7%
Hypolipemia
7%
Nuclear Factor
7%
Glutathione
7%
Overall Survival
7%
Adenosine Triphosphate
6%
Biochemical Recurrence
6%
Medicine and Dentistry
Prostate Cancer
79%
Transitional Cell Carcinoma
51%
Cancer Cell
47%
Meta-Analysis
30%
Metastatic Carcinoma
30%
Neoplasm
30%
Programmed Cell Death
30%
Malignant Neoplasm
29%
Bladder
29%
Nephroureterectomy
27%
Bladder Cancer
27%
Recurrent Disease
26%
Androgen Receptor
23%
Neuroendocrine Differentiation
20%
Symptom
19%
Systematic Review
18%
Prostate Hypertrophy
17%
Signal Transduction
17%
In Vitro
17%
Cohort Analysis
17%
Androgen
16%
Lung Cancer
15%
Clear Cell Renal Cell Carcinoma
15%
Epidermal Growth Factor Receptor
15%
Chronic Kidney Disease
15%
Cancer Growth
15%
Agenesis
14%
Vas Deferens
14%
Autophagy
14%
Spermiogenesis
14%
Reactive Oxygen Species
14%
Overall Survival
14%
Erectile Dysfunction
14%
Urinary System
14%
Carcinoma Cell
13%
Non Small Cell Lung Cancer
13%
Androgen Deprivation Therapy
12%
Disease
12%
Enucleation
12%
Inguinal Hernia
12%
Cell Death
12%
Penfluridol
11%
Oral Cancer
11%
Cytotoxicity
11%
Prostate Specific Antigen
11%
Mitogen-Activated Protein Kinase
11%
Snail
11%
Mesenchymal-Epithelial Transition
10%
Operation Duration
10%
Xenograft
10%
Upregulation
10%
Hernioplasty
10%
Mouth Squamous Cell Carcinoma
10%
Carboplatin
10%
Quercetin
10%
Intracytoplasmic Sperm Injection
10%
Disease Free Survival
10%
Percutaneous Nephrolithotomy
9%
Randomized Controlled Trial
9%
Kidney Function
9%
Cancer Specific Survival
9%
Azoospermia
9%
Cell Proliferation
8%
Quality of Life
8%
Prognostic Factor
8%
Stroma
8%
Upper Urinary Tract
8%
Urinary Retention
8%
Recurrence Free Survival
8%
Protein P53
8%
Maturity Onset Diabetes of the Young
7%
Sperm Motility
7%
Cystic Fibrosis Transmembrane Conductance Regulator
7%
Cancer
7%
Tumor Microenvironment
7%
Injury
7%
Disintegrin
7%
Metalloproteinase
7%
Thrombus
7%
Infection
7%
Curcumin
7%
Testes
7%
Postoperative Complication
7%
Urothelial Cancer
7%
Protein Expression
7%
Hepatocellular Carcinoma
7%
down Regulation
7%
Odds Ratio
7%
Genetic Variability
7%
Nifedipine
7%
Uropathogenic Escherichia Coli
7%
Mesenchymal Stem Cell
7%
Lung Adenocarcinoma
7%
Bicalutamide
7%
Middle Age
7%
Lipopolysaccharide
7%
Leukemia Inhibitory Factor Receptor
7%
Lower Urinary Tract Symptom
7%
Cytokine
6%
Cardiovascular Disease
6%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
55%
Epidermal Growth Factor Receptor
27%
Androgen Receptor
19%
Stem Cell
17%
Upregulation
17%
MicroRNA
16%
Signal Transduction
16%
Quercetin
13%
Cell Proliferation
13%
Allele
13%
Genetic Divergence
12%
Cytokine
12%
Mouse
11%
Promoter Region
11%
Catenin
11%
Tumor Progression
10%
Matrix Metalloproteinase
10%
Messenger RNA
10%
Single-Nucleotide Polymorphism
9%
Autophagy
9%
Cancer Stem Cell
9%
Leukemia Inhibitory Factor Receptor
9%
ADAM9
9%
Genotyping
9%
Interleukin 8
9%
Survival Rate
8%
Lipopolysaccharide
8%
Mesenchymal-Epithelial Transition
8%
Cytotoxicity
8%
MMP2
8%
Gelatinase A
8%
Carcinogenesis
8%
Protein Expression
8%
Disintegrin
7%
Metalloproteinase
7%
Cystic Fibrosis Transmembrane Conductance Regulator
7%
Tumor Volume
7%
Apigenin
7%
Gallic Acid
7%
Muscarinic Acetylcholine Receptor
7%
Proteoglycan
7%
Genetics
7%
Pyruvate Kinase
7%
down Regulation
7%
Tumor Necrosis Factor
7%
Platelet-Rich Plasma
7%
Prostate-Specific Antigen
7%
Doxorubicin
7%
Uropathogenic Escherichia Coli
7%
Nifedipine
7%
Synapsin I
7%
Overall Survival
6%
Biological Activity
6%
Alpha Oxidation
6%
AMP-activated Protein Kinase
6%
Cystic Fibrosis
6%
Fibroblast
6%
Wound Healing
6%
Genetic Variation
6%
Myeloid
6%
Cell Motility
6%
Cell Growth
6%
Lipotoxicity
6%
Spermatogenesis
6%
Cell Invasion
6%
Macrophage
6%
Testosterone Blood Level
6%
Rat Model
5%
Animal Model
5%
Chorioallantoic Membrane Assay
5%
Cohort Study
5%
Ferulic Acid
5%
Case-Control Study
5%
Drive
5%
Vascular Endothelial Growth Factor
5%
Cell Migration
5%
Locus Control Region
5%
Gene Expression
5%
Stromal Cell
5%
Western Blot
5%
Thrombospondin
5%
Passive Smoking
5%
Y Chromosome
5%
Metalloprotease Inhibitor
5%
Polysaccharide
5%
STAT3
5%
Wild Type
5%
Disease Free Survival
5%
Anticancer
5%
Psidium
5%
Sterol Regulatory Element-Binding Protein
5%
Transcription
5%
Cisplatin
5%
Receptor Gene
5%
Magnetism
5%
G1/S Transition
5%